Common antidepressant may help adults with long COVID: study
Global News | Breaking, Latest News and Video for Canada [Unoff…
April 2, 2026
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Discussion in the ATmosphere